Prevalence and correlates of jugular injections among injection drug users

Drug and Alcohol Review

Volumn 27, Issue 4, 2008, Pages 442-446

  Hoda, Zia ^a   Kerr, Thomas ^a,b   Li, Kathy ^a   Montaner, Julio S G ^a,b   Wood, Evan ^a,b,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

HIV; Injection drug use; Jugular; Public health

Indexed keywords

STREET DRUG;

ADULT; ARTICLE; CANADA; COCAINE DEPENDENCE; COHORT ANALYSIS; FEMALE; HEROIN DEPENDENCE; HUMAN; JUGULAR VEIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDY; PROSTITUTION; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE;

ADULT; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; COHORT STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; JUGULAR VEINS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PROSTITUTION; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 46649088327     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230802089701     Document Type: Article

References (27)

1. McCoy CB, Rodriguez F. Global overview of injecting drug use and HIV infection. Lancet 2005;365:1008-9.
2. Sherman SG, Fuller CM, Shah N, Ompad DV, Vlahov D, Strathdee SA. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J Psychoact Drugs 2005;37:437-43.
3. Heimer R, Kaplan EH, Khoshnood K, Jariwala B, Cadman EC. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med 1993;95:214-20.
4. Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction 1999;94:675-83.
5. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000;30:579-81.
6. Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner JS, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J 2005;2:24.
7. Maggi P, Fullone M, Federico M, Angarano G, Pastore G, Regina G. Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected patients? A case report. Angiology 1995;46:1049-52.
8. Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health 2003; 94:355-9.
9. Myers EM, Kirkland LS Jr, Mickey R. The head and neck sequelae of cervical intravenous drug abuse. Laryngoscope 1988;98:213-18.
10. Mesquita F, Kral A, Reingold A, Bueno R, Trigueiros D, Araujo PJ. Trends of HIV infection among injection drug users in Brazil in the 1990s: the impact of changes in patterns of drug use. J Acquir Immune Defic Syndr 2001; 28:298-302.
11. Sheikh MA, Topoulos AP, Deitcher SR. Isolated internal jugular vein thrombosis: risk factors and natural history. Vasc Med 2002;7:177-9.
12. Lin D, Reeck JB, Murr AH. Internal jugular vein thrombosis and deep neck infection from intravenous drug use: management strategy. Laryngoscope 2004;114:56-60.
13. Chowdhury K, Bloom J, Black MJ, al-Noury K. Spontaneous and nonspontaneous internal jugular vein thrombosis. Head Neck 1990;12:168-73.
14. Jackson AL, Cornwell E III, Daniels F. Hemopneumothor-ax in an intravenous drug abuser. J Natl Med Assoc 1995;87:309-11.
15. Bell C, Borak J, Loeffler JR. Pneumothorax in drug abusers: a complication of internal jugular venous injections. Ann Emerg Med 1983;12:167-70.
16. Angelos MG, Sheets CA, Zych PR. Needle emboli to lung following intravenous drug abuse. J Emerg Med 1986; 4:391-6.
17. Raz S, Ramanathan V. Injection injuries of the recurrent laryngeal nerve. Laryngoscope 1984;94:197-200.
18. Cohen JP, Persky MS, Reede DL. Internal jugular vein thrombosis. Laryngoscope 1985;95:1478-82.
19. Lewis JW Jr, Groux N, Elliott JP Jr, Jara FM, Obeid FN, Magilligan DJ Jr. Complications of attempted central venous injections performed by drug abusers. Chest 1980;78:613-17.
20. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-65.
21. Kerr T, Tyndall M, Li K, Montaner JS, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005;366:316-18.
22. Palepu A, Tyndall MW, Leon H, et al. Hospital utilization and costs in a cohort of injection drug users. Can Med Assoc J 2001;165:415-20.
23. Wood E, Li K, Small W, Montaner JS, Schechter MT, Kerr T. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep 2005;120:150-6.
24. Wood E, Tyndall M, Stoltz J, et al. Safer injecting education for HIV prevention within a medically supervised safer injecting facility. Int J Drug Pol 2005;16:281-4.
25. O'Connell J, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J AIDS 2005;40:83-8.
26. Miller CL, Strathdee SA, Li K, Kerr T, Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs). Am J Drug Alcohol Abuse 2007;33:527-36.
27. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999; 353:1657-61.